Resumen de Investigación
Analyzed using Evidence Intelligence™

isCGM does not improve sleep quality in young adults with T1D

Última actualización 29 de agosto de 2026

Key finding

At 6 months, subjective measures for overall sleep quality were similar between the groups.

This study evaluated the impact of intermittently scanned continuous glucose monitoring on sleep patterns in adolescents and young adults with Type 1 diabetes, finding no significant differences in sleep outcomes between the two monitoring methods.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated the impact of intermittently scanned continuous glucose monitoring on sleep patterns in adolescents and young adults with Type 1 diabetes, finding no significant differences in sleep outcomes between the two monitoring methods.

Clinical relevance

Understanding the effects of glucose monitoring methods on sleep is crucial for managing Type 1 diabetes in adolescents and young adults. Since sleep quality can significantly impact overall health and diabetes management, knowing that both isCGM and SMBG have similar effects allows for flexibility in treatment options without compromising sleep.

Keep in mind

The study may have limited generalizability due to the specific age range and diabetes type. Sample size and demographic diversity were not detailed, which could affect findings. The reliance on subjective measures for sleep quality may introduce bias.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Shelley R, Barbara CG, Sara ES, et al. The Impact of Intermittently Scanned Continuous Glucose Monitoring on Sleep Patterns in Adolescents and Young Adults with Type 1 Diabetes: A Randomized Controlled Trial. Pediatric Diabetes. 2023;2023:1842008. doi:10.1155/2023/1842008

Efectos Principales

Overall sleep quality was similar between isCGM and SMBG groups at 6 months.

No significant differences in sleep latency were found after adjusting for age and baseline values.

Sleep duration did not differ significantly across the week for either monitoring method.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Continuous glucose monitoring, Self-monitoring of blood glucose and Average sleep latency at 6 months, Daytime dysfunction, Night sleep duration, and 4 more.

Primary intervention

Continuous glucose monitoring

Primary outcomes

  • Average sleep latency at 6 months
  • Daytime dysfunction
  • Night sleep duration

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

14
Evidence pairs
14
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 51

1

Related topics

14

Evidence pairs

207

Related studies

Why it is useful

  • Contributes to 14 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Agrega evidencia relacionada a tu Evidence Tracker

Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.

Evidencia principal

Relación de evidencia

Insulin Delivery Systems and Quality of Life Outcomes

Evidencia relacionada

Relación de evidencia

Insulin Delivery Systems and Sleep Outcomes

Guardar evidencia

Tema de evidencia

Diabetes Technology

Guardar evidencia

Core evidence

Study findings

The primary outcomes reported in this study.

Average sleep latency at 6 months

Continuous glucose monitoring → Average sleep latency at 6 months

Continuous glucose monitoring → Average sleep latency at 6 months

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Daytime dysfunction

Continuous glucose monitoring → Daytime dysfunction

Continuous glucose monitoring → Daytime dysfunction

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Night sleep duration

Continuous glucose monitoring → Night sleep duration

Continuous glucose monitoring → Night sleep duration

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Night-time disturbances

Continuous glucose monitoring → Night-time disturbances

Continuous glucose monitoring → Night-time disturbances

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Sleep efficiency

Continuous glucose monitoring → Sleep efficiency

Continuous glucose monitoring → Sleep efficiency

Evidence Intelligence™
EvidenceScore™
Moderate
Score 69 · Based on 2 studies
ImpactScore™
75
Positive
ConsistencyScore™
35
mixed
Estudios de apoyo: Basado en 2 estudios
Add to Evidence Tracker

Sleep quality

Continuous glucose monitoring → Sleep quality

Continuous glucose monitoring → Sleep quality

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Use of sleep medications

Continuous glucose monitoring → Use of sleep medications

Continuous glucose monitoring → Use of sleep medications

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Average sleep latency at 6 months

Self-monitoring of blood glucose → Average sleep latency at 6 months

Self-monitoring of blood glucose → Average sleep latency at 6 months

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Daytime dysfunction

Self-monitoring of blood glucose → Daytime dysfunction

Self-monitoring of blood glucose → Daytime dysfunction

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Night sleep duration

Self-monitoring of blood glucose → Night sleep duration

Self-monitoring of blood glucose → Night sleep duration

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Night-time disturbances

Self-monitoring of blood glucose → Night-time disturbances

Self-monitoring of blood glucose → Night-time disturbances

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Sleep efficiency

Self-monitoring of blood glucose → Sleep efficiency

Self-monitoring of blood glucose → Sleep efficiency

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Sleep quality

Self-monitoring of blood glucose → Sleep quality

Self-monitoring of blood glucose → Sleep quality

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Use of sleep medications

Self-monitoring of blood glucose → Use of sleep medications

Self-monitoring of blood glucose → Use of sleep medications

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

La Evidencia Sugiere

  • No significant differences in overall sleep quality between isCGM and SMBG.
  • Regression analyses showed no differences in sleep latency or duration.
  • Findings suggest both monitoring methods are equally effective for sleep.
who this applies

A quién se aplica

  • Adolescents and young adults aged 13-25 with Type 1 diabetes.
  • Individuals using either isCGM or SMBG for glucose monitoring.
keep in mind

Tener en Cuenta

  • Results may not apply to populations outside the studied age range.
  • Further research is needed to explore long-term effects on sleep.
  • Subjective sleep measures may not fully capture sleep disturbances.
between the lines

Entre Líneas

  • The study may have limited generalizability due to the specific age range and diabetes type.
  • Sample size and demographic diversity were not detailed, which could affect findings.
  • The reliance on subjective measures for sleep quality may introduce bias.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Insulin Delivery Systems and Sleep Outcomes, Insulin Delivery Systems and Daytime dysfunction.

Relaciones de evidencia relacionadas

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Insulin Delivery Systems improve quality of life outcomes?

Strong Evidence

Insulin Delivery Systems may improve Quality of Life Outcomes.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The available evidence reports mixed findings.

Ranked evidence signals

  1. 1

    Sleep quality

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

  • Population details are unavailable.
8 supporting studiesUpdated: Aug 2026

Does Insulin Delivery Systems improve sleep outcomes?

Strong Evidence

Insulin Delivery Systems may improve Sleep Outcomes.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

  1. 1

    Sleep efficiency

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 1 study

  2. 2

    Average sleep latency at 6 months

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on 5 supporting studies with generally consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
5 supporting studiesUpdated: Aug 2026

Does Continuous glucose monitoring improve daytime dysfunction?

Emerging Evidence

Current evidence does not show a clear benefit of Continuous glucose monitoring for Daytime dysfunction.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Daytime dysfunction

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026

Does Continuous glucose monitoring improve night sleep duration?

Emerging Evidence

Current evidence does not show a clear benefit of Continuous glucose monitoring for Night sleep duration.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Night sleep duration

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Sin anuncios. Sin rastreo.

Centrada en la evidencia, no en la publicidad.

Segura y privada

Tus datos siempre están protegidos.

Siempre al día

Se agregan nuevos estudios todos los días.